Durable remission related to CAR-T persistence in R/R B-ALL and long-term persistence potential of prime CAR-T-Reference-Cited by-同舟云学术

Durable remission related to CAR-T persistence in R/R B-ALL and long-term persistence potential of prime CAR-T

Published:2023-06 Issue: Volume:29 Page:107-117
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Shiqi Li,Jiasi Zhang,Lvzhe Chen,Huailong Xu,Liping He,Lin Liu,Qianzhen Zhang,Zhongtao Yuan,Junjie Shen,Zucong Chen,Yingzi Zhang,Meiling Wang,Yunyan Li,Linling Wang,Lihua Fang,Yingnian Chen,Wei Zhu,Yu Li,Le Luo,Youcheng Wang,Dingsong Zhang,Yancheng Dong,Ping Yin,Lihua Zhang,Xiaoping Li,Xiaozhuang Hu,Zhongzheng Zheng,Zhi Yang,Cheng Qian,Sanbin Wang

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference32 articles.

1. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial;Lee;Lancet,2015

2. CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients;Turtle;J. Clin. Invest.,2016

3. A review of clinical outcomes of CAR T-cell therapies for B-acute lymphoblastic leukemia;Martino;Int. J. Mol. Sci.,2021

4. Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia;Park;N. Engl. J. Med.,2018

5. Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy;Hay;Blood,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma;Leukemia;2024-01-06

2. INSPIRED Symposium Part 2: Prevention and Management of Relapse Following Chimeric Antigen Receptor T Cell Therapy for B Cell Acute Lymphoblastic Leukemia;Transplantation and Cellular Therapy;2023-11